SANOFI AVENTIS S.A. secures contract for Medicinal Products for the Food Tract and Metabolism - Supply of exclusive drugs with Alflglucosidase Alfa, Vandetanib, Imiglucerase, Dupilumab, Rasburicasa and Sarilumab's active principles of the Sanofi Aventis Pharmaceutical Laboratory, SA for centers dependent on the Murcian Health Service

Spain, July 25 -- Spain based SANOFI AVENTIS S.A. has secured contract from Servicio Murciano de Salud - Junta de Compras for Medicinal Products for the Food Tract and Metabolism - Supply of exclusive drugs with Alflglucosidase Alfa, Vandetanib, Imiglucerase, Dupilumab, Rasburicasa and Sarilumab's active principles of the Sanofi Aventis Pharmaceutical Laboratory, SA for centers dependent on the Murcian Health Service. The value of the contract is worth 62475000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....